[ad_1]
Hedda Holth, press officer at the Oslo University Hospital, confirms this to Dagbladet.
– I can confirm that three health workers have been admitted with a blood clot. They have all been vaccinated with AstraZenaca, but I can’t say when, he says.
It is currently unknown if there is a causal link between the vaccine and severe cases of the disease.
Aftenposten mentioned the case for the first time, but wrote that two health workers had been admitted. Aftenposten reported that these two are relatively young and have received the AstraZeneca vaccine relatively recently.
– The Norwegian Medicines Agency and FHI were informed yesterday of a report from Tynset about an unexpected death as a result of a brain hemorrhage. Today, we have received three more reports from three younger people who have had a blood clot after vaccination with the AstraZeneca vaccine, says Sigurd Hortemo of the Norwegian Medicines Agency during a press conference on Saturday.
– Very serious
FHI Chief Physician Sara Vatle tells Dagbladet that what the three patients have in common is that they have a picture of serious illness.
– All are under 50 years of age and have a very serious illness. They have blood clots, bleeding, and low platelets, Vatle tells Dagbladet.
Furthermore, it says that all three developed symptoms within ten days of vaccination.
Bleeding from the skin
At today’s press conference, it was also announced that several younger people who have received the AstraZeneca vaccine have had major or minor skin bleeds.
– Several younger patients have had skin bleeding after coronary vaccination, says Sigurd Hortemo from the Norwegian Medicines Agency.
– It can be a serious sign of a low platelet count. So we tell people under the age of 50 that if they experience this, they should see a doctor immediately, Hortemo says.
31 persons
Yesterday, the Norwegian Medicines Agency stated that so far a blood clot had been reported in 31 people who had received a corona vaccine in Norway. Most of them were elderly with an underlying disease.
In its weekly report on side effects, the Norwegian Medicines Agency refers to the report of a death in Denmark as a result of a blood clot after vaccination with the AstraZeneca vaccine.
It is currently unknown if there is a connection between death and the vaccine.
Therefore, on Thursday, the National Institute of Public Health decided to put all vaccines with this vaccine on hold while further research is conducted.
The death in Denmark led the Norwegian Medicines Agency to wait to publish the weekly report until they extracted and reviewed all cases of blood clots after coronary vaccination reported to the adverse reaction registry.
In Norway, a blood clot was reported yesterday in a person who had received the AstraZeneca vaccine.
Fear that the rumor will be affected
– Very serious
On Friday it became known that a woman in her 30s, who worked in the municipality of Tynset, died ten days after being vaccinated with the AstraZeneca vaccine.
It is currently unknown if there is a connection between the vaccine and unexpected death.
Steinar Madsen, director of the Norwegian Medicines Agency, emphasized that this death was not caused by a blood clot.
– We take it very seriously, as it is a younger person. We will now collect all available information about this incident from local health personnel and hospitals, to obtain the best possible basis for assessing the cause of this incident, Madsen told Dagbladet on Friday.
He also said that they cannot conclude anything until they have received all the results.
-We must be sure if this may have something to do with vaccination or if it is a coincidence in time, he says.
FHI was taken to bed
– Extremely rare
At a press conference on Friday morning, the Tynset municipal chief stated that a woman died as a result of a brain hemorrhage.
– The person in question was vaccinated and eventually a serious condition developed that ended fatally, Madsen said.
He also said that the person was admitted to the hospital after receiving the vaccine, where he underwent several tests. These are tests that the Norwegian Medicines Agency will review now.
– When a patient has such a serious condition, the person in question performs a series of examinations, all of which are necessary to be able to make a diagnosis, he said and continued:
– But brain hemorrhage at that age is extremely rare. Annually, it occurs in only 4-5 people in people under 45 years of age.
